4//SEC Filing
Fardis Maria 4
Accession 0001104659-20-002086
CIK 0001425205other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 9:00 PM ET
Size
6.0 KB
Accession
0001104659-20-002086
Insider Transaction Report
Form 4
Fardis Maria
DirectorPresident and CEO
Transactions
- Award
Stock Option (right to buy)
2020-01-03+500,000→ 500,000 totalExercise: $25.54Exp: 2030-01-02→ Common stock (500,000 underlying)
Footnotes (1)
- [F1]Provided the Reporting Person is still employed with the Issuer on the following dates, the options are exercisable as follows: (i) options for the purchase of one-third of the 500,000 shares shall vest on the one-year anniversary of January 3, 2020; and (ii) the remaining options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of January 3, 2020.
Documents
Issuer
IOVANCE BIOTHERAPEUTICS, INC.
CIK 0001425205
Entity typeother
Related Parties
1- filerCIK 0001559231
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 9:00 PM ET
- Size
- 6.0 KB